Early Detection Breakthrough: Australian scientists developed a "nanoflower sensor" blood test to detect pregnancy complications like gestational diabetes and preterm birth as early as 11 weeks.
By Aniket Chakraborty
Feb 28, 2025
High Accuracy: The test has over 90% accuracy in identifying risks, offering earlier intervention opportunities compared to current methods.
2
Placental Health Focus: The test measures biomarkers from placental extracellular vesicles, providing insights into placental health and potential complications.
3
Cost-Saving Potential: Early detection could save millions by reducing neonatal ICU admissions and emergency interventions like cesarean sections.
4
Current Limitations: Most complications are detected in the second or third trimester, often too late for effective intervention.
5
Clinical Trials Ahead: The next steps involve a clinical trial with 2,000 women to validate the test, aiming for availability in 3–5 years.
6
Pathway to Accessibility: The goal is to create a point-of-care device, but initial testing could be done through pathology labs for quicker implementation.
7
Impact on Healthcare: The test could revolutionise obstetric care by enabling earlier risk assessment and personalised interventions.
8
Common Complications: The test targets conditions like gestational diabetes (18% of pregnancies) and preeclampsia (5–8% of pregnancies).
9
Future Vision: Researchers aim to make the test as accessible as glucose monitoring, improving outcomes for mothers and babies globally.